"Spike protein detox"

A wellness-community phrase used for protocols intended to clear residual spike protein. It is not a clinical term, not an FDA category, and has no peer-reviewed protocol behind it. We name our site this way because that is what people search — and we use the page to explain what the regulatory and peer-reviewed sources actually say.

Edited by M. Callahan · Last reviewed 2026-05-10

How researchers and regulators frame it

The U.S. FDA has not approved any product for "spike protein detoxification." When manufacturers have marketed supplements with such claims, the FDA has issued warning letters citing misbranding and unapproved drug claims. The agency's official position is that "detox" claims in supplements are not validated for clinical endpoints. The WHO and CDC similarly do not endorse any spike protein detox protocol.

The underlying research question is legitimate. Multiple peer-reviewed studies have detected spike protein or its RNA in tissue reservoirs months after acute COVID-19 in some patients (Patterson et al., 2022, PubMed 35262865; Röltgen et al., Cell, 2022, PubMed 35438856). The NIH's RECOVER initiative is conducting interventional trials to understand whether such persistence is clinically meaningful and whether targeted therapies (including antivirals and immunomodulators) help patients with long COVID.

The wellness-community supplement protocols most often associated with the phrase — nattokinase, bromelain, NAC, quercetin, ivermectin, hydroxychloroquine, and others — are at varying levels of evidence. Some have laboratory or model-system findings that are scientifically interesting. None has a randomized controlled trial demonstrating that it clears spike protein in humans with clinical benefit. The strongest evidence base in any of these is for general antioxidant or anti-inflammatory effects, not for "removing" spike protein.

What this term tends to imply — and what is actually supported